Platelet adenylyl cyclase signaling remains unaltered in children undergoing hemodialysis treatment

R Büscher1, S Keffel, K E Bonzel

  • 1Department of Pediatric Nephrology, University Hospital of Essen, Germany.

Insights

Children undergoing hemodialysis (HD) show normal platelet signal transduction, unlike adults. This suggests pediatric chronic renal failure and HD may not significantly impact blood cell signaling pathways.

Area of Science:

  • Biochemistry
  • Pediatric Nephrology
  • Cellular Signaling

Background:

  • Chronic renal failure (CRF) in adults is linked to endocrine, gastrointestinal, and cardiovascular issues.
  • Alterations in adenylyl cyclase (AC) responsiveness and G-protein expression are implicated in CRF complications.
  • Previous studies noted platelet AC and G-protein abnormalities in adult CRF patients on hemodialysis (HD).

Purpose of the Study:

  • To investigate if children with CRF undergoing HD exhibit similar platelet signal transduction abnormalities as adults.
  • To compare adenylyl cyclase activity and G-protein expression in platelets of pediatric CRF patients and healthy children.

Main Methods:

  • Compared 11 children with CRF on HD to 11 age-matched healthy controls.
  • Assessed platelet adenylyl cyclase (AC) activity under basal and stimulated conditions (receptor agonist, G-protein activators, AC stimulators).
  • Quantified platelet G-protein alpha-subunits using immunoblotting.

Main Results:

  • No significant differences were observed in basal or stimulated platelet AC activity between HD children and controls.
  • Immunoreactivity for platelet G-protein alpha-subunits was comparable in both groups.
  • Pediatric CRF patients on HD showed minimal to no abnormalities in blood cell signal transduction.

Conclusions:

  • Hemodialysis in children with chronic renal failure is associated with fewer signal transduction abnormalities compared to adult patients.
  • Factors like dialysis quality, patient age, and underlying disease may influence these differences.
  • Pediatric CRF may have a less pronounced impact on blood cell signaling pathways than in adults.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...